Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China
· Delayed Price · Currency is CNY 16.32
-0.08 (-0.49%)
Mar 11, 2026, 3:04 PM CST
SHE:300519 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 57.94 | 50.39 | 64.36 | 108.82 | 114.28 | 98.98 | Upgrade
|
| Depreciation & Amortization | 14.93 | 14.93 | 14.77 | 14.05 | 12.86 | 12.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.07 | 0.07 | 0.29 | - | 0.71 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | 0.01 | -0.02 | -0 | 0.49 | 0.72 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.87 | -4.87 | -4.07 | -4.32 | -6.42 | -6.59 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.11 | 0.11 | -0.71 | 0.43 | - | - | Upgrade
|
| Other Operating Activities | 8.04 | 0.39 | 0.5 | 0.2 | - | - | Upgrade
|
| Change in Accounts Receivable | -2.69 | -2.69 | 14.4 | -8.44 | 2.93 | -0.51 | Upgrade
|
| Change in Inventory | 1.69 | 1.69 | -25.78 | 0.42 | -4.46 | 6.08 | Upgrade
|
| Change in Accounts Payable | -6.55 | -6.55 | -10.6 | 15.37 | 22.02 | 1.53 | Upgrade
|
| Operating Cash Flow | 68.64 | 53.43 | 53.29 | 126.43 | 142.36 | 112.61 | Upgrade
|
| Operating Cash Flow Growth | 46.28% | 0.27% | -57.85% | -11.19% | 26.41% | 14.60% | Upgrade
|
| Capital Expenditures | -4.05 | -5.2 | -15.99 | -16.64 | -14.71 | -10.27 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.1 | 0.32 | 0.03 | 0.2 | - | Upgrade
|
| Investment in Securities | -30 | -30 | -40 | 10 | -36.8 | 135.4 | Upgrade
|
| Other Investing Activities | -120.59 | 5.14 | 4.29 | 4.55 | 6.78 | 18.75 | Upgrade
|
| Investing Cash Flow | -154.62 | -29.96 | -51.37 | -2.07 | -44.54 | 143.88 | Upgrade
|
| Common Dividends Paid | -48 | -64 | -80 | -96 | -96 | -72 | Upgrade
|
| Financing Cash Flow | -48 | -64 | -80 | -96 | -96 | -72 | Upgrade
|
| Net Cash Flow | -133.98 | -40.53 | -78.08 | 28.36 | 1.82 | 184.5 | Upgrade
|
| Free Cash Flow | 64.58 | 48.23 | 37.3 | 109.78 | 127.64 | 102.34 | Upgrade
|
| Free Cash Flow Growth | 88.88% | 29.30% | -66.02% | -13.99% | 24.72% | 24.40% | Upgrade
|
| Free Cash Flow Margin | 25.12% | 18.02% | 13.80% | 31.23% | 39.78% | 36.15% | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.30 | 0.23 | 0.69 | 0.79 | 0.64 | Upgrade
|
| Cash Income Tax Paid | 31.28 | 23.4 | 44.9 | 36 | 44.76 | 43.56 | Upgrade
|
| Levered Free Cash Flow | 33.04 | 23.2 | 7.05 | 71.83 | 87.81 | 68.95 | Upgrade
|
| Unlevered Free Cash Flow | 33.04 | 23.2 | 7.05 | 71.83 | 87.81 | 68.95 | Upgrade
|
| Change in Working Capital | -7.59 | -7.59 | -21.83 | 7.24 | 20.43 | 6.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.